Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)

Clinical trial NCT01135615 · COMPLETED

Trial details

NCT number: NCT01135615
Sponsor: Gulhane School of Medicine
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

We Investigated the Relationship Between Plasma FGF23 Levels and Endothelial Dysfunction in a Sizable Series of Incident Stage 3-4 CKD Patients.

Start date: 2008-01-01
Primary completion: 2010-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.